Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT Fatigue – High-dose thiamine for fatigue in rheumatoid arthritis
2024-519268-41-00Phase 4Authorised
- Sponsor
- University Hospital Odense
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing High-dose thiamine with Placebo (2 arms). Primary endpoint: Change in BRAF-MDQ global score at 4 weeks. Planned start Jun 2026; status: authorised.
02
Drugs
thiamine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2024-519268-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519268-41-00.